(Q36490750)

14 August 2017

1 reference

title

Mechanisms of immune evasion by tumors (English)

1 reference

evasion of host immune response

14 August 2017

1 reference

2

Elizabeth Jaffee

1 reference

14 August 2017

Charles G Drake

1

1 reference

PubMed ID

16730261

14 August 2017

Drew M Pardoll

series ordinal

3

1 reference

14 August 2017

1 January 2006

1 reference

14 August 2017

Advances in Immunology

1 reference

14 August 2017

90

1 reference

14 August 2017

51-81

1 reference

CD4+ T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells

14 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

TGF-beta 1 attenuates the acquisition and expression of effector function by tumor antigen-specific human memory CD8 T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

A minor population of splenic dendritic cells expressing CD19 mediates IDO-dependent T cell suppression via type I IFN signaling following B7 ligation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Initiating cellular stress responses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Mutations of the beta2-microglobulin gene result in a lack of HLA class I molecules on melanoma cells of two patients immunized with MAGE peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Major histocompatibility complex-restricted recognition of retroviral superantigens by V beta 17+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Altered binding of regulatory factors to HLA class I enhancer sequence in human tumor cell lines lacking class I antigen expression

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Role of transforming growth factor beta in human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Naive CD4+ T cells confer idiotype-specific tumor resistance in the absence of antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Deletion of idiotype (Id)-specific T cells in multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

SPI-CI and SPI-6 cooperate in the protection from effector cell-mediated cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

1 reference

7 January 2021

IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Neuropilin-1: a surface marker of regulatory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

High frequency of altered HLA class I phenotypes in invasive breast carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

High frequency of altered HLA class I phenotypes in invasive colorectal carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Identification of novel inhibitors of the transforming growth factor beta1 (TGF-beta1) type 1 receptor (ALK5).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Postmodern cancer: the role of human immunodeficiency virus in uterine cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Comparative analysis of the in vivo expression of tyrosinase, MART-1/Melan-A, and gp100 in metastatic melanoma lesions: implications for immunotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Natural variation of the expression of HLA and endogenous antigen modulates CTL recognition in an in vitro melanoma model

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

The evolving crosstalk between co-stimulatory and co-inhibitory receptors: HVEM-BTLA.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

TGFbeta1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Heterogeneous expression of the SSX cancer/testis antigens in human melanoma lesions and cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

The tumoricidal activity of memory CD8+ T cells is hampered by persistent systemic antigen, but full functional capacity is regained in an antigen-free environment.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect in B2m gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Recruitment of latent pools of high-avidity CD8(+) T cells to the antitumor immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Histocompatibility antigens in primary and metastatic squamous cell carcinoma of the larynx

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Lack of MHC class I antigens and tumour aggressiveness of the squamous cell carcinoma of the larynx

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

MHC class I antigens and tumour-infiltrating leucocytes in laryngeal cancer: long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

A genetic model for colorectal tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Cancer vaccines: between the idea and the reality

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Transforming growth factor-beta1 level correlates with angiogenesis, tumor progression, and prognosis in patients with nonsmall cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Antigenic specificities on murine sarcoma cells. Reciprocal relationship between normal transplantation antigens (H-2) and tumor-specific immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

The expression of histocompatibility-related leukocyte antigens in the pathway to cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Role of LAG-3 in regulatory T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Timing of deletion of autoreactive V β6+ cells and down-modulation of either CD4 orCD8 on phenotypically distinct CD4+8+ subsets of thymocytes expressingintermediate or high levels of T cell receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Rejection of transplantable AKR leukaemia cells following MHC DNA-mediated cell transformation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

B and T lymphocyte attenuator exhibits structural and expression polymorphisms and is highly Induced in anergic CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Immunoselection in vivo: independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

The fundamental role of epigenetic events in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

T cell tolerance by clonal elimination in the thymus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

NF-kappaB: linking inflammation and immunity to cancer development and progression

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

IL6 and IL6 receptor expression in Burkitt's lymphoma and lymphoblastoid cell lines: promotion of IL6 receptor expression by EBV

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Role of immature myeloid cells in mechanisms of immune evasion in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Inhibitory MHC class I receptors on NK cells and T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Clonal deletion of thymocytes as a tumor escape mechanism.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Fingerprints of anergic T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Mouse tumor rejection antigens P815A and P815B: two epitopes carried by a single peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Regulation of immune responses by TGF-beta

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

The macrophage growth factor CSF-1 in mammary gland development and tumor progression

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Tumor necrosis factor receptor 1-mediated signaling is required for skin cancer development induced by NF-kappaB inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Differential induction of transcriptionally active p53 following UV or ionizing radiation: defects in chromosome instability syndromes?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

A spontaneously arising pancreatic tumor does not promote the differentiation of naive CD8+ T lymphocytes into effector CTL.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

T-cell receptor V beta use predicts reactivity and tolerance to Mlsa-encoded antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Expression of the serpin serine protease inhibitor 6 protects dendritic cells from cytotoxic T lymphocyte-induced apoptosis: differential modulation by T helper type 1 and type 2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Selective changes in expression of HLA class I polymorphic determinants in human solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Hyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Regulation of dendritic cell differentiation and antitumor immune response in cancer by pharmacologic-selective inhibition of the janus-activated kinase 2/signal transducers and activators of transcription 3 pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Cross-linking the B7 family molecule B7-DC directly activates immune functions of dendritic cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Tumor growth enhances cross-presentation leading to limited T cell activation without tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Immunological ignorance of solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Immune surveillance against a solid tumor fails because of immunological ignorance

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Short-term kinetics of tumor antigen expression in response to vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Cancer immunotherapy: breaking the barriers to harvest the crop

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Maintenance of in vivo tolerance by persistence of antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Loss of functional beta 2-microglobulin in metastatic melanomas from five patients receiving immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Phenotypic expression of histocompatibility antigens in human primary tumours and metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

The expression of transforming growth factor-beta1 is significantly correlated with the expression of vascular endothelial growth factor and poor prognosis of patients with advanced gastric carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Molecular characterization of defective antigen processing in human prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Keratinocyte-specific ablation of Stat3 exhibits impaired skin remodeling, but does not affect skin morphogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

In situ analysis of transforming growth factor-beta s (TGF-beta 1, TGF-beta 2, TGF-beta 3), and TGF-beta type II receptor expression in malignant melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

T-cell clonal anergy.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Preoperative plasma levels of transforming growth factor beta(1) strongly predict clinical outcome in patients with bladder carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Preoperative plasma levels of transforming growth factor beta(1) (TGF-beta(1)) strongly predict progression in patients undergoing radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Regulatory/suppressor T cells in health and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Cooperative B7-1/2 (CD80/CD86) and B7-DC costimulation of CD4+ T cells independent of the PD-1 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Induction of antigen-specific T cell anergy: An early event in the course of tumor progression

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Tolerogenic dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Effective inhibition of cell growth and invasion of melanoma by combined suppression of BRAF (V599E) and Skp2 with lentiviral RNAi.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

T-cell apoptosis detected in situ during positive and negative selection in the thymus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Immunoregulatory T cells in tumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Stat3 activation by Src induces specific gene regulation and is required for cell transformation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

A novel platinum compound inhibits constitutive Stat3 signaling and induces cell cycle arrest and apoptosis of malignant cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Mechanisms of syngeneic tumor rejection. Susceptibility of host-selected progressor variants to various immunological effector cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

HLA antigens in colorectal tumours--low expression of HLA class I antigens in mucinous colorectal carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Association of allele-specific HLA expression and histopathologic progression of cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Tumour escape from immune surveillance through dendritic cell inactivation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Mechanisms of suppression by suppressor T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Abrogation of metastatic properties of tumour cells by de novo expression of H–2K antigens following H–2 gene transfection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Lack of HLA class I antigen expression by melanoma cells SK-MEL-33 caused by a reading frameshift in beta 2-microglobulin messenger RNA

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Tumor antigens defined by cloned immunological probes are highly polymorphic and are not detected on autologous normal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Expression of major histocompatibility antigens and leucocyte infiltration in benign and malignant human breast disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Multiple tumour-specific antigens expressed on a single tumour cell

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Human squamous cell carcinomas of the head and neck chemoattract immune suppressive CD34(+) progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Viral immune evasion due to persistence of activated T cells without effector function

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Adoptive transfer of tumor-reactive transforming growth factor-beta-insensitive CD8+ T cells: eradication of autologous mouse prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Immunohistochemical analysis of HLA antigens and mononuclear infiltrates of benign and malignant breast

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Heterogeneity of the expression of class I and II HLA antigens in human breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

Molecular analysis of MHC-class-I alterations in human tumor cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990002-9

7 January 2021

10.1016/S0065-2776(06)90002-9

Identifiers

DOI

1 reference

14 August 2017

1 reference

PubMed ID

16730261